Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The goal of this phase 2, multicenter, randomized, controlled study is to evaluate the effect
of albumin treatment on B cell and other immune cell gene exptression in adults with septic
shock.